The sentiment on D-Street is fragile that despite opening higher in the previous session, the markets fell like ninepins in the last hour of trading session and moreover, Nifty breached its 9,000 mark.

On Tuesday, Nucleus Software, a leading provider of lending and transaction banking solutions to the global financial services industry, announced the launch of the latest version of its transaction banking solution-FinnAxia 7.0.

The broader indices represented by BSE Mid-cap and Small-cap closed down by 1.84 per cent and 2.20 per cent, respectively. The Mid-cap index was topped by BEL that closed with gains of six per cent while, Future was the top loser to settle down by 10 per cent on Tuesday.

Dr Reddy's Laboratories Ltd announced the launch of Ziprasidone Mesylate for injection, 20 mg (base)/ml single-dose Vials in US market.

Every coin has a flip side and mutual funds are no different in that sense. Fund managers do not only buy but also sell. It becomes equally important to know what they are selling. So, let’s find out.

Shares of Yes Bank were trading deep in green on Tuesday, continuing the momentum from the previous day after the rating agency-Moody's upgraded the private lender's outlook and RBI Governor provided assurance to the troubled bank.

Alembic Pharmaceuticals announced that the company’s API facility located at Karakhadi has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA).

The board of directors of Sun Pharmaceutical Industries has approved share buyback amid broad market sell-off. The board in today’s meeting, approved equity share buyback of Rs 1,700 crore at a maximum price of Rs 425 apiece, which represents nearly 15 per cent premium from Monday’s closing

The share price of Grasim Industries Limited slipped three per cent in the early morning trade session on Tuesday after CCI imposed a penalty on the company.

There is a reason to be pessimist now; however, a long-term view makes the equity market attractive!